Safety, pharmacokinetics, and pharmacodynamics of PD 0348292, an oral, direct factor Xa inhibitor, after single and multiple dosings in healthy subjects

20153 citationsJournal Article

Authors

The safety, pharmacokinetics, and pharmacodynamics of PD 0348292 were acceptable for future clinical development.

Good health and well-being

Published in: Clinical Pharmacology in Drug Development

Volume 5, Issue 1, pp. 13-26

Field-Weighted Citation Impact: 0.21